Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.23%8.36B | -3.73%8.34B | 13.03%2.43B | 4.42%2.1B | -0.20%1.78B | -25.31%2.03B | -19.19%8.66B | -0.98%2.15B | -30.18%2.01B | -39.68%1.78B |
| Cost of revenue | -0.31%7.57B | -2.26%7.59B | 12.83%2.2B | 3.80%1.9B | -0.44%1.64B | -20.85%1.85B | -17.52%7.76B | 0.12%1.95B | -27.39%1.83B | -35.96%1.65B |
| Gross profit | 5.69%793.53M | -16.42%750.82M | 14.93%235.92M | 10.71%198.79M | 2.87%134.08M | -52.49%182.03M | -31.27%898.33M | -10.30%205.27M | -49.84%179.55M | -65.26%130.34M |
| Operating expense | 17.70%839.13M | -2.14%712.92M | -2.34%182.95M | 4.70%185.55M | -8.98%159.29M | -2.04%185.14M | -6.60%728.53M | -15.50%187.34M | -15.13%177.21M | -2.62%175M |
| Staff costs | 0.48%266.91M | 5.07%265.63M | ---- | ---- | ---- | ---- | -9.64%252.82M | ---- | ---- | ---- |
| Selling and administrative expenses | 4.26%267.39M | 7.36%256.45M | ---- | ---- | ---- | ---- | -8.69%238.88M | ---- | ---- | ---- |
| -General and administrative expense | 4.26%267.39M | 7.36%256.45M | ---- | ---- | ---- | ---- | -8.69%238.88M | ---- | ---- | ---- |
| Research and development costs | 1,241.96%65.88M | --4.91M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other operating expenses | 28.52%238.95M | -21.49%185.93M | ---- | ---- | ---- | ---- | -0.74%236.83M | ---- | ---- | ---- |
| Operating profit | -220.30%-45.6M | -77.68%37.9M | 195.42%52.97M | 466.21%13.24M | 43.56%-25.2M | -101.60%-3.1M | -67.79%169.8M | 151.03%17.93M | -98.43%2.34M | -122.85%-44.66M |
| Net non-operating interest income (expenses) | -9.67%60.48M | 42.25%66.95M | 38.62%19.09M | 48.07%17.92M | 75.96%17.26M | 11.40%12.69M | 4.34%47.07M | 5.10%13.77M | 0.60%12.1M | -9.71%9.81M |
| Non-operating interest income | -8.42%61.31M | 42.20%66.95M | 38.61%19.09M | 48.04%17.92M | 75.87%17.26M | 11.34%12.69M | 4.21%47.08M | 5.00%13.77M | 0.47%12.1M | -9.83%9.81M |
| Non-operating interest expense | --832K | --0 | --0 | --0 | --0 | --0 | -79.17%15K | -92.31%1K | -83.33%3K | -73.68%5K |
| Net investment income | 223.03%41.19M | -76.12%12.75M | -183.17%-33.27M | 2,048.35%25.43M | 162.92%10.3M | -66.88%10.29M | -13.32%53.38M | -16.04%40M | -105.51%-1.31M | -67.50%-16.38M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -15.68%5.34M | -33.34%6.34M | 0 | 0 | 9.51M | 9.51M | 0 | |||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 93.68%-1.12M | 86.65%-17.69M | 88.02%-14.93M | 2.21%-1.33M | -81.57%-739K | 88.77%-690K | -1,946.61%-132.52M | -11,611.28%-124.61M | 45.08%-1.36M | 70.49%-407K |
| Less:Other special charges | 241.90%1.12M | -91.13%327K | -15.34%657K | 97.99%-11K | 109.52%36K | -109.25%-355K | 59.84%3.69M | 18.11%776K | -177.07%-548K | -217.76%-378K |
| Less:Write off | --0 | -86.53%17.36M | -88.47%14.27M | -29.76%1.34M | -10.45%703K | -54.76%1.05M | 2,990.24%128.83M | 30,325.55%123.83M | 8.24%1.91M | -25.80%785K |
| Other non-operating income (expenses) | -11.79%57.32M | 572.54%64.98M | -47.99%1.33M | 2,330.95%56.54M | 6.44%1.01M | 59.39%6.1M | -65.94%9.66M | -59.66%2.57M | -75.95%2.33M | -73.56%947K |
| Income before tax | -31.31%117.61M | 9.13%171.23M | 161.69%25.19M | 692.67%111.8M | 117.68%8.96M | -89.21%25.28M | -76.07%156.9M | -155.81%-40.84M | -92.66%14.1M | -125.51%-50.69M |
| Income tax | -9.02%70.48M | -42.15%77.46M | -4.60%31.76M | 43,529.63%35.34M | -108.41%-2.21M | -83.06%12.57M | -49.70%133.9M | -49.71%33.29M | -99.88%81K | -64.94%26.29M |
| Net income | -49.73%47.13M | 307.68%93.77M | 91.14%-6.57M | 445.19%76.46M | 114.51%11.17M | -92.06%12.71M | -94.09%23M | -1,163.57%-74.13M | -88.66%14.02M | -162.21%-76.98M |
| Net income continuous operations | -49.73%47.13M | 307.68%93.77M | 91.14%-6.57M | 445.23%76.46M | 114.51%11.17M | -92.06%12.71M | -94.09%23M | -1,163.42%-74.13M | -88.66%14.02M | -162.21%-76.98M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -49.73%47.13M | 307.68%93.77M | 91.14%-6.57M | 445.19%76.46M | 114.51%11.17M | -92.06%12.71M | -94.09%23M | -1,163.57%-74.13M | -88.66%14.02M | -162.21%-76.98M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -49.73%47.13M | 307.68%93.77M | 91.14%-6.57M | 445.19%76.46M | 114.51%11.17M | -92.06%12.71M | -94.09%23M | -1,163.57%-74.13M | -88.66%14.02M | -162.21%-76.98M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -49.73%15.07 | 307.89%29.98 | 91.14%-2.1 | 445.76%24.45 | 114.51%3.57 | -92.07%4.06 | -93.94%7.35 | -964.96%-23.7 | -88.31%4.48 | -164.19%-24.61 |
| Diluted earnings per share | -49.73%15.07 | 307.89%29.98 | 91.14%-2.1 | 445.64%24.4446 | 114.51%3.57 | -92.07%4.06 | -93.94%7.35 | -1,163.61%-23.7 | -88.31%4.48 | -164.20%-24.6109 |
| Dividend per share | -16.67%10 | -7.69%12 | 133.33%7 | 0 | -50.00%5 | 0 | -48.00%13 | -80.00%3 | 0 | 0.00%10 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |